How do molecular diagnostics contribute to personalized cancer therapy?
Molecular diagnostics involve analyzing DNA, RNA, and proteins to detect specific genetic alterations and biomarkers associated with cancer. Techniques such as fluorescence in situ hybridization (FISH), real-time PCR, and next-generation sequencing are employed to identify mutations, gene fusions, and expression profiles. These insights enable the development of targeted therapies that are tailored to the genetic makeup of an individual's tumor, improving treatment efficacy and reducing side effects.
